Global Medical Polymer Market was valued US$ XX in 2018 and is estimated to surpass US$ XX Billion market in at a Compound Annual Growth Rate (CAGR) of XX % during the forecast period 2019-2026 globally. Global medical polymer market is driven by rising geriatric population and prevalence of chronic diseases, which significantly boosted demand for medical implants. In addition, medical polymer market is witnessing high growth globally owing to the high acceptance and adoption of polymers for product manufacturing. Increasing geriatric population is expected to result in the rise in healthcare facilities which is expected to drive the industry growth. This is expected to aid the growth for medical devices and therefore have a positive impact on the overall medical polymers market. Increasing bio-compatibility of plastics has also been a significant cause for the medical polymer industry growth. Medical polymer possess low weight compared to the metallic material hence are preferred for a variety of applications in medical industry. Medical grade fibers & resins will dominate the market by 2026, attributed to its superior properties such as high thermal and chemical resistance together with ease of sterilization. Fibers and resin segment accounted for the largest share in 2017 owing to high use in various applications including hip & joint replacement surgeries, spinal implants, and different injuries. While biodegradable plastics is estimated to grow at highest CAGR of 16.1% over the forecast period in terms of revenue, owing to health concerns regarding synthetic polymers. Increasing expenditure on healthcare along with the presence of well-equipped hospitals have a positive impact on hospital accessories segment growth. Increasing demand for surgical instruments and tools such as gloves, clamps, forceps, syringes, surgical trays, medical bags, and catheters is expected to drive demand for medical polymers over the forecast period. Medical polymer segment has further dominated the hospital accessories segment due to their high flexibility, low manufacturing cost, and high infection resistance compared to other metallic materials. Implants application segment held the largest market share in 2017, due to a high demand for implants for replacement surgeries such as a knee, hip, joint, and dental. Demand for implants is growing primarily due to increased incidences of chronic diseases and increasing global geriatric population. Applications such as cardio implants and devices and tissue engineering may propel the growth of the global market in the near future. Polymers are widely used in the medical sector, including diagnostic systems, implants, and accessories. Intraocular lenses, contact lenses, facial implants, vascular grafts, breast implants, catheters, dental implants, and prosthetic hearth valves are a few examples of where the medical polymers are used. North America accounted for the largest share of the medical polymer market followed by Europe, and the Asia Pacific. North America is dominant owing to increased prevalence of chronic disease, and a high transplant surgery rate. In addition, the population having a higher awareness of health benefits like low product cost and enhanced performance polymers have further boosted the overall growth. Also, the presence of major manufacturers and their well-established network in the region have also helped in the overall growth. Asia Pacific region is expected to see growth in medical polymer market during the current forecast period due to the rising awareness for low cost but advanced materials and their related benefits. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding medical polymer market dynamics, structure by identifying and analyzing the market segments and project the market size. Further, the report also focuses on a competitive analysis of key players by product, price, financial position, Purity portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER's analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in medical polymer market.
The Scope of the Global Medical Polymer Market:
Global Medical Polymer Market, By Product type:• Fibres and Resins • Medical Elastomers • Biodegradable Medical Polymers
Global Medical Polymer Market, By Application:• Implants • Diagnostic Systems • Hospital Accessories
Global Medical Polymer Market, By Geography:• North America • Europe • Asia Pacific • Latin America • Middle East and Africa
Key Players analyzed in the Report:• Eastman Chemical Company • Evonik Industries AG • The Dow Chemical Company • Formosa Plastics Corporation USA • Arkema SA • BASF SE • Covestro AG • DSM N.V. • Solvay S.A • Celanese Corporation • Victrex Plc. • DuPont • Tianjin Plastics Research Institute Co. Ltd • Lubrizol Corporation • Bayer • Celanese • Eastman Chemical • Borealis • DSM • ExxonMobil • Huizhou Foryou Medical Devices • Kraton Performance Polymers • Victrex VCSEL Market
Table of Contents
Global Medical Polymer Market1. INTRODUCTION 1.1 Market description & Scope (2019-2026) 1.2 Objectives 1.2.1 Key Takeaways 1.2.2 Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1 Methods used for market forecasting 2.2 Data Sources 2.2.1 Paid Databases 2.2.2 Primary Sources 2.2.3 Secondary Sources 3. EXECUTIVE SUMMARY 3.1 Major Findings 3.1.1 Key Segment Trends 18.104.22.168 Product Type 22.214.171.124 Application 3.1.2 Key Regional Trends 3.2 Key Companies and their Strategies 4. MARKET OVERVIEW 4.1 Medical Polymer Concept & Definition 4.2 Segments Overview 4.2.1 By Product Type 126.96.36.199 Fibers and Resins 188.8.131.52 Biodegradable Medical Polymers 4.2.2 By Application 184.108.40.206 Implants 220.127.116.11 Diagnostic Systems 18.104.22.168 Hospital Accessories 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.3.3 Opportunities 4.4 Porter’s Analysis 4.5 PESTLE Analysis 4.6 Fragmentation 4.6.1 Key strategic Alliances of companies (inorganic & organic) 4.6.2 Company Market Share (Top 10 Players) 4.6.3 Comparative Analysis of Key Players in Medical Polymer 4.7 Key Trends In Global Medical Polymer Market 5. GLOBAL MEDICAL POLYMER PRODUCT TYPE ESTIMATES & TREND ANALYSIS (2019-2026) 5.1 Global Medical Polymer Market: Product Type Analysis 5.1.1 Fibers and Resins 22.214.171.124 Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.2 Medical Elastomers 126.96.36.199 Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.3 Biodegradable Medical Polymers 188.8.131.52 Market Share and growth forecasts, 2019-2026 (USD Billion) 5.2 Global Medical Polymer Market: Product Type Trends 6. GLOBAL MEDICAL POLYMER APPLICATION ESTIMATES & TREND ANALYSIS (2019-2026) 6.1 Global Medical Polymer Market: Application Analysis 6.1.1 Implants 184.108.40.206 Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.2 Diagnostic Systems 220.127.116.11 Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.3 Hospital Accessories 18.104.22.168 Market Share and growth forecasts, 2019-2026 (USD Billion) 6.2 Global Medical Polymer Market: Application Trends 7. REGIONAL ESTIMATES & TREND ANALYSIS (2019-2026) 7.1 Global Medical Polymer Market share by Region, 2018 & 2026 7.2 North America 7.2.1 North America Medical Polymer, Market Share and growth forecasts, 2019-2026 (USD Billion) 7.2.2 Medical Polymer Drivers for North America Market 7.2.3 Market Share Analysis and Growth Forecast, by Country 22.214.171.124 US 126.96.36.199 Canada 188.8.131.52 Rest of North America 7.2.4 Country-wise GDP Growth Forecast 7.2.5 Medical Polymer Trends In North America Market 7.3 Europe 7.3.1 Europe Medical Polymer, Market Share and growth forecasts, 2019-2026 (USD Billion) 7.3.2 Medical Polymer Drivers for Europe Market 7.3.3 Market Share Analysis and Growth Forecast, by Country 184.108.40.206 UK 220.127.116.11 Germany 18.104.22.168 Italy 22.214.171.124 France 126.96.36.199 Rest of Europe 7.3.4 Country-wise GDP Growth Forecast 7.3.5 Medical Polymer Trends in Europe Market 7.4 Asia Pacific 7.4.1 Asia Pacific Medical Polymer, Market Share and growth forecasts, 2019-2026 (USD Billion) 7.4.2 Medical Polymer Drivers for Asia Pacific Market 7.4.3 Market Share Analysis and Growth Forecast, by Country 188.8.131.52 China 184.108.40.206 Japan 220.127.116.11 India 18.104.22.168 Australia 22.214.171.124 Rest of Asia Pacific 7.4.4 Country-wise GDP Growth Forecast 7.4.5 Medical Polymer Trends in Asia Pacific Market 7.5 Latin America 7.5.1 Latin America Medical Polymer, Market Share and growth forecasts, 2019-2026 (USD Billion) 7.5.2 Medical Polymer Drivers for Latin America Market 7.5.3 Market Share Analysis and Growth Forecast, by Country 126.96.36.199 Brazil 188.8.131.52 Mexico 184.108.40.206 Rest of Latin America 7.5.4 Country-wise GDP Growth Forecast 7.5.5 Medical Polymer Trends in Latin America Market 7.6 Middle East & Africa 7.6.1 Middle East & Africa Medical Polymer, Market Share and growth forecasts, 2019-2026 (USD Billion) 7.6.2 Medical Polymer Drivers for Middle East & Africa Market 7.6.3 Market Share Analysis and Growth Forecast, by Country 220.127.116.11 GCC 18.104.22.168 South Africa 22.214.171.124 Rest of Middle East & Africa 7.6.4 Country-wise GDP Growth Forecast 7.6.5 Medical Polymer Trends in Middle East & Africa Market 8. MARKET SHARE ANALYSIS 8.1 Key Players Regional Market share Analysis 8.1.1 US 8.1.2 Canada 8.1.3 UK 8.1.4 Germany 8.1.5 Italy 8.1.6 France 8.1.7 China 8.1.8 Japan 8.1.9 India 9. MARKET COMPETITION ANALYSIS 9.1 Strategy Framework 9.2 Consolidation 9.2.1 Patent Analysis 9.2.2 Mergers & Acquisitions 126.96.36.199 Product Based 188.8.131.52 Services Based 184.108.40.206 Region Based 220.127.116.11 List of Mergers & Acquisitions 9.2.3 Company Benchmarking (Revenue & Profit Based) 9.2.4 Strategic Assessment of Company Consolidations 9.2.5 Emerging Business Models 9.3 Company Profiles 9.3.1 Eastman Chemical Company 18.104.22.168 Company overview 22.214.171.124 Key financials 126.96.36.199 Geographical presence 188.8.131.52 Product and Business Segments 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 18.104.22.168 Competitive positioning and landscape 9.3.2 Evonik Industries AG 22.214.171.124 Company overview 126.96.36.199 Key financials 188.8.131.52 Geographical presence 184.108.40.206 Product and Business Segments 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis 22.214.171.124 Competitive positioning and landscape 9.3.3 The Dow Chemical Company 126.96.36.199 Company overview 188.8.131.52 Key financials 184.108.40.206 Geographical presence 220.127.116.11 Product and Business Segments 18.104.22.168 Strategic initiatives 22.214.171.124 SWOT analysis 126.96.36.199 Competitive positioning and landscape 9.3.4 Formosa Plastics Corporation USA 188.8.131.52 Company overview 184.108.40.206 Key financials 220.127.116.11 Geographical presence 18.104.22.168 Product and Business Segments 22.214.171.124 Strategic initiatives 126.96.36.199 SWOT analysis 188.8.131.52 Competitive positioning and landscape 9.3.5 Arkema SA 184.108.40.206 Company overview 220.127.116.11 Key financials 18.104.22.168 Geographical presence 22.214.171.124 Product and Business Segments 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 184.108.40.206 Competitive positioning and landscape 9.3.6 BASF SE 220.127.116.11 Company overview 18.104.22.168 Key financials 22.214.171.124 Geographical presence 126.96.36.199 Product and Business Segments 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis 220.127.116.11 Competitive positioning and landscape 9.3.7 Covestro AG 18.104.22.168 Company overview 22.214.171.124 Key financials 126.96.36.199 Geographical presence 188.8.131.52 Product and Business Segments 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 18.104.22.168 Competitive positioning and landscape 9.3.8 DSM N.V. 22.214.171.124 Company overview 126.96.36.199 Key financials 188.8.131.52 Geographical presence 184.108.40.206 Product and Business Segments 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis 22.214.171.124 Competitive positioning and landscape 9.3.9 Solvay S.A 126.96.36.199 Company overview 188.8.131.52 Key financials 184.108.40.206 Geographical presence 220.127.116.11 Product and Business Segments 18.104.22.168 Strategic initiatives 22.214.171.124 SWOT analysis 126.96.36.199 Competitive positioning and landscape 9.3.10 Celanese Corporation 188.8.131.52 Company overview 184.108.40.206 Key financials 220.127.116.11 Geographical presence 18.104.22.168 Product and Business Segments 22.214.171.124 Strategic initiatives 126.96.36.199 SWOT analysis 188.8.131.52 Competitive positioning and landscape 9.3.11 Victrex Plc. 184.108.40.206 Company overview 220.127.116.11 Key financials 18.104.22.168 Geographical presence 22.214.171.124 Product and Business Segments 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 184.108.40.206 Competitive positioning and landscape 9.3.12 DuPont 220.127.116.11 Company overview 18.104.22.168 Key financials 22.214.171.124 Geographical presence 126.96.36.199 Product and Business Segments 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis 220.127.116.11 Competitive positioning and landscape 9.3.13 Tianjin Plastics Research Institute Co. Ltd 18.104.22.168 Company overview 22.214.171.124 Key financials 126.96.36.199 Geographical presence 188.8.131.52 Product and Business Segments 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 18.104.22.168 Competitive positioning and landscape 9.3.14 Lubrizol Corporation 22.214.171.124 Company overview 126.96.36.199 Key financials 188.8.131.52 Geographical presence 184.108.40.206 Product and Business Segments 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis 22.214.171.124 Competitive positioning and landscape 9.3.15 Bayer 126.96.36.199 Company overview 188.8.131.52 Key financials 184.108.40.206 Geographical presence 220.127.116.11 Product and Business Segments 18.104.22.168 Strategic initiatives 22.214.171.124 SWOT analysis 126.96.36.199 Competitive positioning and landscape 9.3.16 Celanese 188.8.131.52 Company overview 184.108.40.206 Key financials 220.127.116.11 Geographical presence 18.104.22.168 Product and Business Segments 22.214.171.124 Strategic initiatives 126.96.36.199 SWOT analysis 188.8.131.52 Competitive positioning and landscape 9.3.17 Eastman Chemical 184.108.40.206 Company overview 220.127.116.11 Key financials 18.104.22.168 Geographical presence 22.214.171.124 Product and Business Segments 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 184.108.40.206 Competitive positioning and landscape 9.3.18 Borealis 220.127.116.11 Company overview 18.104.22.168 Key financials 22.214.171.124 Geographical presence 126.96.36.199 Product and Business Segments 188.8.131.52 Strategic initiatives 184.108.40.206 SWOT analysis 220.127.116.11 Competitive positioning and landscape 9.3.19 DSM 18.104.22.168 Company overview 22.214.171.124 Key financials 126.96.36.199 Geographical presence 188.8.131.52 Product and Business Segments 184.108.40.206 Strategic initiatives 220.127.116.11 SWOT analysis 18.104.22.168 Competitive positioning and landscape 9.3.20 ExxonMobil 22.214.171.124 Company overview 126.96.36.199 Key financials 188.8.131.52 Geographical presence 184.108.40.206 Product and Business Segments 220.127.116.11 Strategic initiatives 18.104.22.168 SWOT analysis 22.214.171.124 Competitive positioning and landscape 9.3.21 Huizhou Foryou Medical Devices 126.96.36.199 Company overview 188.8.131.52 Key financials 184.108.40.206 Geographical presence 220.127.116.11 Product and Business Segments 18.104.22.168 Strategic initiatives 22.214.171.124 SWOT analysis 126.96.36.199 Competitive positioning and landscape 9.3.22 Kraton Performance Polymers 188.8.131.52 Company overview 184.108.40.206 Key financials 220.127.116.11 Geographical presence 18.104.22.168 Product and Business Segments 22.214.171.124 Strategic initiatives 126.96.36.199 SWOT analysis 188.8.131.52 Competitive positioning and landscape 9.3.23 Victrex 184.108.40.206 Company overview 220.127.116.11 Key financials 18.104.22.168 Geographical presence 22.214.171.124 Product and Business Segments 126.96.36.199 Strategic initiatives 188.8.131.52 SWOT analysis 184.108.40.206 Competitive positioning and landscape